Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s...
Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Arzneimittel-Agentur (EMA) die...
(ビジネスワイヤ) -- シャンハイ・ヘンリウス・バイオテック(2696.HK)とオルガノン(NYSE:OGN)は、欧州医薬品庁(EMA)が、Prolia®およびXgeva ®(デ...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the...
Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women’s health, announced today that it, together with Organon...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.